Výsledky vyhledávání

Control of cell cycle progression in human mesothelioma cells treated with gamma interferon

Autor: Jocelyne Fleury-Feith, I Monnet, F Levy, P Chretien, Y. Pilatte, Claire Vivo, Laurence Kheuang, M C Jaurand

Publikováno v: Oncogene. 20:1085-1093

Recombinant human interferon gamma (r-hu-IFNgamma) exerts both antitumoral activity in the early stages of human malignant mesothelioma and a cytostatic effect in human mesothelioma (HM) cell lines in vitro. The antiproliferative effect of interferon

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5aa019fce72fb26d3de81f68a3b6a84
https://doi.org/10.1038/sj.onc.1204199

Zobrazit plný text záznamu

The target antigens of naturally occurring human anti-β-galactose IgG are cryptic on porcine aortic endothelial cells

Autor: Julia Lucq, Anne Marie Guinault, Daniel Loisance, Anne Greffard, D. Tixier, Y. Pilatte

Publikováno v: Xenotransplantation. 7:3-13

The identification of the xeno-antigens/xeno-antibodies combinations involved in pig-to-human xenograft rejection is an essential step for understanding this process and for the development of procedures to prevent it. Although it is widely accepted

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dc48d68a690a63a8e1a6f5243e7e91ff
https://doi.org/10.1034/j.1399-3089.2000.00041.x

Zobrazit plný text záznamu

Differentiation between vascular permeability factor and IL-2 in lymphocyte supernatants from patients with minimal-change nephrotic syndrome

Autor: G. Lagrue, Heslan Jm, Y. Pilatte, Branellec A, Peter Lang

Publikováno v: Clinical and Experimental Immunology. 86:157-162

SUMMARY Immunolherapy of cancers with recombinant IL-2 induces a vascular leak syndrome which is mainly due to an increase in vascular permeability. A lymphokine, the vascular permeability factor (VPF), which increases vascular permeability, has been

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a70a2e5af75566a082e72a1fcb21892
https://doi.org/10.1111/j.1365-2249.1991.tb05789.x

Zobrazit plný text záznamu

The target antigens of naturally occurring human anti-beta-galactose IgG are cryptic on porcine aortic endothelial cells

Autor: J, Lucq, D, Tixier, A M, Guinault, A, Greffard, D, Loisance, Y, Pilatte

Publikováno v: Xenotransplantation. 7(1)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7d1a7dd2c6643fad6b249a542271fd22
https://pubmed.ncbi.nlm.nih.gov/10809052

Zobrazit plný text záznamu

Shedding of CD44 from PMA-differentiated U-937 cells is enhanced by treatment with mineral particles

Autor: Laurence Kheuang, Marie Claude Jaurand, Noureddine Trabelsi, Jean Bignon, Anne Greffard, Y. Pilatte, Jean Claude Pairon

Publikováno v: Biochemical and biophysical research communications. 245(1)

In this report, we show that enhanced shedding of CD44 might contribute to the down-regulation of this receptor observed after phagocytosis of MnO 2 particles by PMA-differentiated U-937. The apparent Mr of the soluble CD44 detected in culture supern

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24596145506ac30c200c499b7667ed9d
https://pubmed.ncbi.nlm.nih.gov/9535816

Zobrazit plný text záznamu

Human malignant mesothelioma cell growth: activation of janus kinase 2 and signal transducer and activator of transcription 1alpha for inhibition by interferon-gamma

Autor: A, Buard, C, Vivo, I, Monnet, C, Boutin, Y, Pilatte, M C, Jaurand

Publikováno v: Cancer research. 58(4)

Intrapleural injections of recombinant human IFN-gamma have shown some efficacy in reducing tumor growth in early stages of diffuse malignant mesothelioma (DMM). Here, we have addressed the potential therapeutic effect of IFN-gamma in DMM by investig

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e8ed4c22494a975099f42473cc11836e
https://pubmed.ncbi.nlm.nih.gov/9485044

Zobrazit plný text záznamu

Immunomodulation with low-dose immunoglobulins for moderate IgA nephropathy and Henoch-Schönlein purpura. Preliminary results of a prospective uncontrolled trial

Autor: G, Rostoker, D, Desvaux-Belghiti, Y, Pilatte, M, Petit-Phar, C, Philippon, L, Deforges, H, Terzidis, L, Intrator, C, André, S, Adnot

Publikováno v: Nephron. 69(3)

Recently, our group has shown that a 3-month course of intravenous immunoglobulin (2 g/kg/monthly) followed by 6 months of intramuscular immunoglobulins (IMIG, 16.5%, 0.35 ml/kg every 15 days) was able to slow or to stop the decline in the glomerular

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::fafca5c85ce84287ceec08b169acec74
https://pubmed.ncbi.nlm.nih.gov/9200429

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání